Surety Medicine

Last Updated: February 05, 2018
Man in hazmat suit

​Surety medicine focuses on protecting the health of the personnel who deal with nuclear, biological or chemical materials, and on medical requirements compliance to help ensure the security of the materials.

FEBRUARY 2018 SURETY MEDICINE TELECONFERENCE

Wednesday, 21 February 2018 will bring the next Surety Medicine Teleconference, at 1 pm (1300 hrs) Eastern Time.  The topic for February is "Ergonomics and the Personnel Reliability Program.”  The presenter will be a Department of Defense Industrial Hygienist with more than twenty two years’ experience who currently supports a major U.S. Biological Surety program site.

To request additional information, email the Army Public Health Center Surety Medicine Division at:
usarmy.apg.medcom-phc.mbx.surety-medicine@mail.mil.


SCHEDULE OF SURETY MEDICINE TELECONFERENCES FOR FY 2018

DateDescription
21 FEB 2018Ergonomics and the Personnel Reliability Program
21 MAR 2018Updates in the Diagnosis and Treatment of Nerve & Vesicant Agent Exposures
18 APR 2018 Hearing Conservation and Audiometric Testing in Surety Programs 
16 MAY 2018 HIV:  CD4 Counts, Antiretroviral Drugs, and Impaired Immune Functions in PRP
27 JUN 2018 Diagnosis, Evaluation and Screening of Laboratory-Acquired Alpha Virus Infections
18 JUL 2018 Screening Diabetics for Reliability and Suitability in the PRP
15 AUG 2018 Case Studies in Personnel Reliability Program Surety Management
26 SEP 2018 Animal Worker Occupational Health Issues in the PRP

--ALERT--

Auto-Injector Shelf Life Extension Program: 

NERVE AGENT ANTIDOTE SHELF LIFE EXTENSION PROGRAM

Three production lots of atropine nerve agent antidote auto-injectors expired 31 January 2018!  In addition, many expiration date extensions for auto-injector medications expired in 2017!  Check any auto-injector medication stores you have.  Select the link below for additional information.

The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote(R)  combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to 2022.  Complete FDA information related to the auto-injector shelf life extension program can be found at this  FDA Drug Safety Page.

Information on this page also includes the latest updates (6/26/2017) on shelf life extensions for the AtroPen(R) (atropine), CANA (diazepam), morphine sulfate, and pralidoxime chloride auto-injectors.